GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Japanese
Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
Latest Information
Read more
04/15/2022
Information
GNI Group FY2021 Annual General Meeting Q&A Summary
01/31/2022
Information
Frequently Asked Questions Updated File (2022-JAN-31)
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(Etuary)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
Investor Relations
IR News
Financial Reports
Conference Material/Convocation Letter
TSE Filings
Bulletin Board
Information
Message
Business Model
Stock Quote
